Stay updated on Vaccine Therapy with Pembrolizumab in Prostate Cancer Clinical Trial
Sign up to get notified when there's something new on the Vaccine Therapy with Pembrolizumab in Prostate Cancer Clinical Trial page.

Latest updates to the Vaccine Therapy with Pembrolizumab in Prostate Cancer Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedThe page’s displayed revision/version number has been updated from v3.5.2 to v3.5.3, reflecting a change in the ClinicalTrials.gov page build rather than the underlying study record.SummaryDifference0.0%

- Check25 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check54 days agoChange DetectedRevision label updated to v3.5.0 on the page, replacing the previous v3.4.3.SummaryDifference0.0%

- Check61 days agoChange DetectedThe page now displays Revision: v3.4.3, replacing the previous Revision: v3.4.2.SummaryDifference0.0%

- Check90 days agoChange DetectedRevision: v3.4.2 was added and the funding-status notice (along with the v3.4.1 note) was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check97 days agoChange DetectedAdded a government funding lapse notice banner stating the NIH Clinical Center is open and directing users to cc.nih.gov. Updated the page's revision identifier from v3.4.0 to v3.4.1.SummaryDifference0.4%

Stay in the know with updates to Vaccine Therapy with Pembrolizumab in Prostate Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Vaccine Therapy with Pembrolizumab in Prostate Cancer Clinical Trial page.